Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

NSE:ADVENZYMES Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	764.24	942.25	1,138	964.2	2,674	1,919
Short-Term Investments	5,293	177.98	295.2	263.37	16.33	54.9
Trading Asset Securities	-	4,803	4,029	3,596	1,019	1,213
Cash & Short-Term Investments	6,057	5,923	5,461	4,823	3,709	3,187
Cash Growth	19.47%	8.45%	13.23%	30.03%	16.38%	54.57%
Accounts Receivable	1,253	1,154	985.68	1,003	884.91	872.31
Other Receivables	-	7.09	15.9	20.06	63.54	23.55
Receivables	1,256	1,162	1,003	1,025	949.31	896.59
Inventory	1,734	1,573	1,485	1,240	1,209	938.81
Prepaid Expenses	-	36.24	39.63	23.23	20.97	19.66
Other Current Assets	287.78	104.48	109.44	110.27	155.55	117.89
Total Current Assets	9,335	8,799	8,097	7,221	6,044	5,160
Property, Plant & Equipment	3,155	3,146	3,073	2,888	2,718	2,510
Long-Term Investments	0.64	56.25	1.71	1.7	0.7	0.7
Goodwill	3,481	3,334	3,253	3,209	2,961	2,887
Other Intangible Assets	504.34	523.08	582.86	608.78	663.06	746.74
Long-Term Deferred Tax Assets	117.47	101.92	142.82	113.42	74.2	68.68
Other Long-Term Assets	326.27	252.16	203.84	176.73	215.04	187.96
Total Assets	16,919	16,213	15,355	14,218	12,676	11,562
Accounts Payable	293.01	172.01	157.59	242.21	178.97	152.17
Accrued Expenses	-	166.81	141.97	124.55	124.62	121.28
Short-Term Debt	-	111.45	175.8	49.89	19.2	46.92
Current Portion of Long-Term Debt	109.6	10.54	3.58	1.96	5.99	42.93
Current Portion of Leases	77.59	62.34	65.54	59.37	57.28	51.89
Current Income Taxes Payable	12.96	45.92	91.41	14.84	1.99	1.89
Other Current Liabilities	574.15	398.48	427.68	282.84	216.17	258.48
Total Current Liabilities	1,067	967.55	1,064	775.66	604.22	675.56
Long-Term Debt	86.89	90.29	66.52	72.77	73.53	93.16
Long-Term Leases	72.46	118.88	161.64	151	191.3	44.73
Pension & Post-Retirement Benefits	-	12.15	7.15	4.13	7.58	9.87
Long-Term Deferred Tax Liabilities	337.82	336.34	343.24	372.27	392.5	408.5
Other Long-Term Liabilities	18.78	1.56	1.71	0.93	3.1	3.69
Total Liabilities	1,583	1,527	1,644	1,377	1,272	1,236
Common Stock	223.76	223.76	223.65	223.65	223.6	223.46
Additional Paid-In Capital	-	840.22	821.31	821.31	813.55	789.56
Retained Earnings	-	11,570	10,834	10,062	9,022	8,016
Comprehensive Income & Other	14,622	1,575	1,363	1,244	826.43	680.3
Total Common Equity	14,845	14,209	13,241	12,351	10,886	9,709
Minority Interest	490.25	478.07	469.52	491.02	517.93	616.82
Shareholders' Equity	15,336	14,687	13,711	12,842	11,404	10,326
Total Liabilities & Equity	16,919	16,213	15,355	14,218	12,676	11,562
Total Debt	346.54	393.5	473.08	334.99	347.3	279.63
Net Cash (Debt)	5,710	5,529	4,988	4,488	3,362	2,908
Net Cash Growth	24.12%	10.85%	11.14%	33.49%	15.63%	68.25%
Net Cash Per Share	50.98	49.37	44.58	40.14	30.05	25.99
Filing Date Shares Outstanding	111.95	111.88	111.82	111.82	111.8	111.73
Total Common Shares Outstanding	111.95	111.88	111.82	111.82	111.8	111.73
Working Capital	8,267	7,831	7,034	6,445	5,440	4,485
Book Value Per Share	132.60	127.00	118.41	110.45	97.37	86.90
Tangible Book Value	10,860	10,351	9,405	8,533	7,262	6,075
Tangible Book Value Per Share	97.01	92.52	84.11	76.31	64.96	54.38
Land	-	574.43	568.36	559.12	517.39	517.39
Buildings	-	843.09	730.58	723.47	627.92	587.94
Machinery	-	2,958	2,666	2,500	2,342	2,165
Construction In Progress	-	216.91	307.37	156.09	96.28	48.62
Leasehold Improvements	-	127.05	126.51	115.34	103.32	102.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.